Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
2,079
Views
4
CrossRef citations to date
0
Altmetric
COVID-19
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States
Michele A. Kohlia Quadrant Health Economics Inc., Cambridge, ON, CanadaCorrespondence[email protected]
, Michael Maschioa Quadrant Health Economics Inc., Cambridge, ON, Canada
, Keya Joshib Moderna, Inc., Cambridge, MA, USA
, Amy Leea Quadrant Health Economics Inc., Cambridge, ON, Canada
, Kelly Fusta Quadrant Health Economics Inc., Cambridge, ON, Canada
, Ekkehard Beckb Moderna, Inc., Cambridge, MA, USA
, Nicolas Van de Veldeb Moderna, Inc., Cambridge, MA, USA
https://orcid.org/0000-0003-4358-5873
Milton C. Weinsteinc Harvard T.H. Chan School of Public Health, Boston, MA, USA
show all
Pages 1532-1545
|
Received 27 Sep 2023, Accepted 06 Nov 2023, Published online: 27 Nov 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.